GABAergic dysfunction in mood disorders
- PMID: 12888801
- DOI: 10.1038/sj.mp.4001362
GABAergic dysfunction in mood disorders
Abstract
The authors review the available literature on the preclinical and clinical studies involving GABAergic neurotransmission in mood disorders. Gamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter present almost exclusively in the central nervous system (CNS), distributed across almost all brain regions, and expressed in interneurons modulating local circuits. The role of GABAergic dysfunction in mood disorders was first proposed 20 years ago. Preclinical studies have suggested that GABA levels may be decreased in animal models of depression, and clinical studies reported low plasma and CSF GABA levels in mood disorder patients. Also, antidepressants, mood stabilizers, electroconvulsive therapy, and GABA agonists have been shown to reverse the depression-like behavior in animal models and to be effective in unipolar and bipolar patients by increasing brain GABAergic activity. The hypothesis of reduced GABAergic activity in mood disorders may complement the monoaminergic and serotonergic theories, proposing that the balance between multiple neurotransmitter systems may be altered in these disorders. However, low GABAergic cortical function may probably be a feature of a subset of mood disorder patients, representing a genetic susceptibility. In this paper, we discuss the status of GABAergic hypothesis of mood disorders and suggest possible directions for future preclinical and clinical research in this area.
Similar articles
-
GABA and affective disorders.Med Biol. 1987;65(2-3):159-65. Med Biol. 1987. PMID: 2821330 Review.
-
GABA function in mood disorders: an update and critical review.Life Sci. 1998;63(15):1289-303. doi: 10.1016/s0024-3205(98)00241-0. Life Sci. 1998. PMID: 9768867 Review.
-
Dysregulation of GABAergic neurotransmission in mood disorders: a postmortem study.Ann N Y Acad Sci. 2007 Jan;1096:157-69. doi: 10.1196/annals.1397.081. Ann N Y Acad Sci. 2007. PMID: 17405927
-
Magnetic resonance spectroscopy studies of GABA in neuropsychiatric disorders.J Clin Psychiatry. 2003;64 Suppl 3:7-14. J Clin Psychiatry. 2003. PMID: 12662128 Review.
-
Plasma GABA in mood disorders.Psychopharmacol Bull. 1990;26(2):157-61. Psychopharmacol Bull. 1990. PMID: 2236451
Cited by
-
Human-Induced Pluripotent Stem Cell (iPSC)-Derived GABAergic Neuron Differentiation in Bipolar Disorder.Cells. 2024 Jul 15;13(14):1194. doi: 10.3390/cells13141194. Cells. 2024. PMID: 39056776 Free PMC article.
-
Depression, an unmet health need in Africa: Understanding the promise of ketamine.Heliyon. 2024 Mar 28;10(7):e28610. doi: 10.1016/j.heliyon.2024.e28610. eCollection 2024 Apr 15. Heliyon. 2024. PMID: 38601594 Free PMC article. Review.
-
LPS-induced inflammation reduces GABAergic interneuron markers and brain-derived neurotrophic factor in mouse prefrontal cortex and hippocampus.Brain Behav Immun Health. 2024 Mar 21;38:100761. doi: 10.1016/j.bbih.2024.100761. eCollection 2024 Jul. Brain Behav Immun Health. 2024. PMID: 38586282 Free PMC article.
-
Plasma amino acids in major depressive disorder: between pathology to pharmacology.EXCLI J. 2024 Jan 4;23:62-78. doi: 10.17179/excli2023-6767. eCollection 2024. EXCLI J. 2024. PMID: 38357097 Free PMC article. Review.
-
A pontomesencephalic PACAPergic pathway underlying panic-like behavioral and somatic symptoms in mice.Nat Neurosci. 2024 Jan;27(1):90-101. doi: 10.1038/s41593-023-01504-3. Epub 2024 Jan 4. Nat Neurosci. 2024. PMID: 38177337 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical